Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Gabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, Katharina Blatt, Gregor Eisenwort, Wolfgang R. Sperr, Gregor Hoermann, Karin Lind, Alexander W. Hauswirth, Peter Bettelheim, Heinz Sill, Junia V. Melo, Ulrich Jäger, Peter Valent
Published Jun 28, 2017 · Vol. 8, No. 40 · pp. 67709-67722
Danielle M. Greenawalt, Winnie S. Liang, Sakina Saif, Justin Johnson, Petar Todorov, Austin Dulak, Daniel Enriquez, Rebecca Halperin, Ambar Ahmed, Vladislav Saveliev, John Carpten, David Craig, J. Carl Barrett, Brian Dougherty, Michael Zinda, Stephen Fawell, Jonathan R. Dry, Kate Byth
Published Jun 15, 2017 · Vol. 8, No. 59 · pp. 99237-99244